Left Ventricular Assist Devices: A Primer
... heart. • Assists the left ventricle in passing oxygenated blood through the body. • Initially was a pulsatile device (similar to native heart…) ...
... heart. • Assists the left ventricle in passing oxygenated blood through the body. • Initially was a pulsatile device (similar to native heart…) ...
Cardiac Conditions - Kentucky Academy of Family Physicians
... Unexplained syncope/near-syncope† Excessive exertional and unexplained dyspnea/fatigue, associated with exercise Prior recognition of a heart murmur Elevated systemic blood pressure *Parental verification is recommended for high school and middle school athletes †Judged not to be neurocardio ...
... Unexplained syncope/near-syncope† Excessive exertional and unexplained dyspnea/fatigue, associated with exercise Prior recognition of a heart murmur Elevated systemic blood pressure *Parental verification is recommended for high school and middle school athletes †Judged not to be neurocardio ...
Position of the Heart
... superior vena cava , then into the right atrium. • The pacemaker overrides the impulse from the SA node. ...
... superior vena cava , then into the right atrium. • The pacemaker overrides the impulse from the SA node. ...
Chronic valvular disease
... mitral stenosis——compensatory hypertrophy of left atrium——congestion of lung——pulmonary artery hypertension——congestion of right ventricle——right heart insufficiency—— congestion of systemic circulation ...
... mitral stenosis——compensatory hypertrophy of left atrium——congestion of lung——pulmonary artery hypertension——congestion of right ventricle——right heart insufficiency—— congestion of systemic circulation ...
Cardiovascular 22 – Heart Valve Disease
... Echocardiogram – shows left atrial and ventricular dilation. Cardiac catheterisation – blood is seen regurgitating from LV to LA. TREATMENT Continuous monitoring with echocardiogram when sufficiently severe, surgical intervention by valve repair or replacement may be necessary. Mitral Valve Pr ...
... Echocardiogram – shows left atrial and ventricular dilation. Cardiac catheterisation – blood is seen regurgitating from LV to LA. TREATMENT Continuous monitoring with echocardiogram when sufficiently severe, surgical intervention by valve repair or replacement may be necessary. Mitral Valve Pr ...
Managing Chronic Heart Failure
... Class 1: Ordinary physical activity doesn’t cause undue fatigue, dyspnea, or anginal pain. Class II: Asymptomatic at rest, slight limitations of physical activity. Ordinary physical activity causes palpitations, dyspnea, & anginal pain. Class III: Marked limitations of physical activity, but asympto ...
... Class 1: Ordinary physical activity doesn’t cause undue fatigue, dyspnea, or anginal pain. Class II: Asymptomatic at rest, slight limitations of physical activity. Ordinary physical activity causes palpitations, dyspnea, & anginal pain. Class III: Marked limitations of physical activity, but asympto ...
Rhythms That Go Bump in the Night
... leads or t wave inversion and see ST elevation on stress testing of the RV leads Positive signal average EKG Treatment is ICD +/- Ablation ...
... leads or t wave inversion and see ST elevation on stress testing of the RV leads Positive signal average EKG Treatment is ICD +/- Ablation ...
PERIPARTUM CARDIOMYOPATHY
... These physical signs may confuse and there could be mistakes in the form of over diagnosis or disregarding of heart disease. ...
... These physical signs may confuse and there could be mistakes in the form of over diagnosis or disregarding of heart disease. ...
Peripartum cardiomyopathy
... These physical signs may confuse and there could be mistakes in the form of over diagnosis or disregarding of heart disease. ...
... These physical signs may confuse and there could be mistakes in the form of over diagnosis or disregarding of heart disease. ...
Cardiology Notes
... The second heart sound comprises of aortic (A2) and pulmonary (P2) component. In LBBB, the aortic closure is delayed because the left ventricle contracts later. This then causes reversed splitting (A2P2 → P2A2) if the second heart sound. LBBB and left heart strain in HCM and aortic stenosis can caus ...
... The second heart sound comprises of aortic (A2) and pulmonary (P2) component. In LBBB, the aortic closure is delayed because the left ventricle contracts later. This then causes reversed splitting (A2P2 → P2A2) if the second heart sound. LBBB and left heart strain in HCM and aortic stenosis can caus ...
Critical Left Ventricular Outflow Tract Obstruction Study
... Assemble a multi-institutional inception cohort of infants with critical LVOTO undergoing all currently available treatment strategies Identify risk factors that are predictive of late outcomes Determine the value of emerging management strategies Assess late outcomes by functional assessment, quali ...
... Assemble a multi-institutional inception cohort of infants with critical LVOTO undergoing all currently available treatment strategies Identify risk factors that are predictive of late outcomes Determine the value of emerging management strategies Assess late outcomes by functional assessment, quali ...
Slide ()
... Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed routinely, as determined by age, symptoms, and coronary risk factors. Cardiac catheterization and angiography may also be helpful when there is a discrepancy between clini ...
... Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed routinely, as determined by age, symptoms, and coronary risk factors. Cardiac catheterization and angiography may also be helpful when there is a discrepancy between clini ...
Hypertrophic cardiomyopathy (HCM)
... population. In most cases it is genetic and does not usually affect children until they reach adolescence, but occasionally it does manifest at younger ages. It has been estimated that children only account for about 10% of HCM cases. Not everyone with HCM will have any symptoms – which is why scree ...
... population. In most cases it is genetic and does not usually affect children until they reach adolescence, but occasionally it does manifest at younger ages. It has been estimated that children only account for about 10% of HCM cases. Not everyone with HCM will have any symptoms – which is why scree ...
Ventricular Tachyarrhythmia
... The goal of long-term therapy is to prevent sudden cardiac death and recurrence of symptomatic VT. Asymptomatic nonsustained ventricular arrhythmias in low-risk populations (preserved LV function) often need not be treated. In patients with symptomatic nonsustained tachycardia, beta blockers are fr ...
... The goal of long-term therapy is to prevent sudden cardiac death and recurrence of symptomatic VT. Asymptomatic nonsustained ventricular arrhythmias in low-risk populations (preserved LV function) often need not be treated. In patients with symptomatic nonsustained tachycardia, beta blockers are fr ...
Hypertrophic cardiomyopathy (HCM)
... population. In most cases it is genetic and does not usually affect children until they reach adolescence, but occasionally it does manifest at younger ages. It has been estimated that children only account for about 10% of HCM cases. Not everyone with HCM will have any symptoms – which is why scree ...
... population. In most cases it is genetic and does not usually affect children until they reach adolescence, but occasionally it does manifest at younger ages. It has been estimated that children only account for about 10% of HCM cases. Not everyone with HCM will have any symptoms – which is why scree ...
Successful Resuscitation After Prolonged Cardiac Arrest in a Patient
... Background: Sudden cardiac death (SCD) is a feared event in patients with hypertrophic cardiomyopathy (HCM), and most commonly afflicts those younger than 35 years old [1]. The risk of SCD has an estimated incidence of 1-2% per year. Risk factors for cardiac arrest in patients with HCM include a fam ...
... Background: Sudden cardiac death (SCD) is a feared event in patients with hypertrophic cardiomyopathy (HCM), and most commonly afflicts those younger than 35 years old [1]. The risk of SCD has an estimated incidence of 1-2% per year. Risk factors for cardiac arrest in patients with HCM include a fam ...
Surgical Therapy for Heart Failure
... (end-diastolic volume index >100 mL/m2) Depressed LVEF Left ventricular regional dyskinesis or akinesis >30 percent of the ventricular perimeter, and Either symptoms of angina, heart failure, or arrhythmias ...
... (end-diastolic volume index >100 mL/m2) Depressed LVEF Left ventricular regional dyskinesis or akinesis >30 percent of the ventricular perimeter, and Either symptoms of angina, heart failure, or arrhythmias ...
Ventricular Ectopic Beats: How Many is Too Much?
... VA in elite athletes free of cardiovascular abnormalities Paradoxically, trained athletes with the smallest extent of LV remodeling demonstrated a tendency to more frequent VA ...
... VA in elite athletes free of cardiovascular abnormalities Paradoxically, trained athletes with the smallest extent of LV remodeling demonstrated a tendency to more frequent VA ...
Management of Feline Heart Disease. In
... The aims of home therapy are to eliminate abnormal fluid retention, modulate neurohormonal activation, and prevent thromboembolism. Oral furosemide: 1-4 mg/kg q12-24h PO. Titrate dose to eliminate pulmonary oedema, or until unacceptable azotaemia develops. Decrease dose once congestive signs cleared ...
... The aims of home therapy are to eliminate abnormal fluid retention, modulate neurohormonal activation, and prevent thromboembolism. Oral furosemide: 1-4 mg/kg q12-24h PO. Titrate dose to eliminate pulmonary oedema, or until unacceptable azotaemia develops. Decrease dose once congestive signs cleared ...
HT, LDL , DM, etc
... Sudden cardiac arrest is the sudden, unexpected loss of heart function, breathing and consciousness. Sudden cardiac arrest usually results from an electrical disturbance in your heart that disrupts its pumping action, stopping blood flow to the rest of your body. Sudden cardiac arrest is diff ...
... Sudden cardiac arrest is the sudden, unexpected loss of heart function, breathing and consciousness. Sudden cardiac arrest usually results from an electrical disturbance in your heart that disrupts its pumping action, stopping blood flow to the rest of your body. Sudden cardiac arrest is diff ...
Fact Sheet 57| CARDIOMYOPATHIES This fact sheet describes a
... may have a variation in the instruction that causes the gene to no longer function properly. This variation is called a mutation or pathogenic variant, and means that the product produced by the gene, called a protein, is impaired or even absent. Gene mutations may be inherited from a parent, or occ ...
... may have a variation in the instruction that causes the gene to no longer function properly. This variation is called a mutation or pathogenic variant, and means that the product produced by the gene, called a protein, is impaired or even absent. Gene mutations may be inherited from a parent, or occ ...
Biochemistry - U
... failure. Mural thrombi. Gross: of ventricular wall (asymmetric septal hypertrophy) Micro: disoriented and tangled myocardial fibers. May result from endocardial disease of myocardial processes (amyloidosis). Thinning and fibrosis of right ventricle. ...
... failure. Mural thrombi. Gross: of ventricular wall (asymmetric septal hypertrophy) Micro: disoriented and tangled myocardial fibers. May result from endocardial disease of myocardial processes (amyloidosis). Thinning and fibrosis of right ventricle. ...
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a primary disease of the myocardium (the muscle of the heart) in which a portion of the myocardium is hypertrophied (thickened) without any obvious cause, creating functional impairment of the cardiac muscle. It is a leading cause of sudden cardiac death in young athletes.The occurrence of hypertrophic cardiomyopathy is a significant cause of sudden unexpected cardiac death in any age group and as a cause of disabling cardiac symptoms. Younger people are likely to have a more severe form of hypertrophic cardiomyopathy.HCM is frequently asymptomatic until sudden cardiac death, and for this reason some suggest routinely screening certain populations for this disease.A cardiomyopathy is a disease that affects the muscle of the heart. With HCM, the myocytes (cardiac contractile cells) in the heart increase in size, which results in the thickening of the heart muscle. In addition, the normal alignment of muscle cells is disrupted, a phenomenon known as myocardial disarray. HCM also causes disruptions of the electrical functions of the heart. HCM is most commonly due to a mutation in one of nine sarcomeric genes that results in a mutated protein in the sarcomere, the primary component of the myocyte (the muscle cell of the heart). These are predominantly single-point missense mutations in the genes for beta-myosin heavy chain (MHC), myosin-binding protein C, cardiac troponinT, or tropomyosin. These mutations cause myofibril and myocyte structural abnormalities and possible deficiencies in force generation. Not to be confused with dilated cardiomyopathy or any other cardiomyopathy.While most literature so far focuses on European, American, and Japanese populations, HCM appears in all ethnic groups. The prevalence of HCM is about 0.2% to 0.5% of the general population.